14 drug(s) with this reaction
27,481 total reports
Decreased Appetite has been reported as an adverse reaction across 14 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 27,481 adverse event reports mention decreased appetite in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with decreased appetite, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have decreased appetite listed in their FDA adverse event reports, sorted by report count:
In addition to decreased appetite, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
14 drug(s) manufactured by Abbvie Inc have decreased appetite listed in their FDA adverse event reports: Humira, ADALIMUMAB, LEVOTHYROXINE SODIUM, FENOFIBRATE, VENETOCLAX, and others.
There are a combined 27,481 reports of decreased appetite across 14 Abbvie Inc drug(s) in the FDA adverse event database.